MBA Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
MBA Advisors's AMGN Position: Q3 2026 in Review
MBA Advisors increased its Amgen (AMGN) stake by 0.03% in Q3 2026, buying an estimated $399 and bringing the position to 3,169 shares worth $1.34M. The position accounts for 0.44% of the portfolio, ranked #44.
MBA Advisors first reported a position in AMGN in Q1 2021 and has held it in 23 quarters since. 2,024 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- MBA Advisors held 3,169 shares of Amgen worth $1.34M as of Q3 2026.
- MBA Advisors bought 1 Amgen share in Q3 2026, an estimated $399.
- Amgen made up 0.44% of MBA Advisors's portfolio in Q3 2026, its #44 holding.
- MBA Advisors first reported a position in Amgen in Q1 2021 and has held it in 23 quarters since.
- 2,024 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on MBA Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.